Vaccine Asia

Vaccine Asia Live: Overcoming the Challenges of Vaccine Trials to Address the Growing Demand in Asia

Seeing the great importance of vaccine development in Asia due to its great demand, it is pertinent that any challenges in vaccine development be addressed, especially in vaccine clinical trials. To help address these challenges, Dr Teoh Yee Leong, CEO of Singapore Clinical Research Institute(SCRI) , spoke about what these challenges were and advice on how to overcome them. Singapore …

Vaccine Asia Live: NIAID’s Effort on Dengue Vaccine R&D

Addressing Asia’s needs for vaccines in dengue, Dr Zou Lanling, Bacteriology Program Officer & Chief of Translational Sciences Section of National Institutes of Health USA, shared the efforts put into dengue vaccine R&D by National Institute of Allergy and Infectious Diseases(NIAID). NIAID conducts and supports research to develop vaccines, therapeutics and diagnostics to help understand, treat, and prevent infectious, immunologic, …

Vaccine Asia Live: Forging Partnerships for Improved Immunisation in Laos

“Vaccination as the most cost-efficient method to save millions of lives around the world.” To kick-start the 2nd day’s activities for World Vaccine Congress Asia 2014, we have the privilege and honour in having Dr Bounkong Syhavong, the Vice Minister of Health for Lao People’s Democratic Republic to present on the forging of partnerships for improved immunisation in Laos. For the …

Vaccine

Vaccine Asia Live: Novel Vaccines for Emerging Diseases

Most vaccines developed target infectious diseases and cancer, with cancer vaccines being listed more under therapeutic vaccines. To enlighten us on vaccines for infectious diseases, Ms Zhang Xiaoshu, Director of Business Development at BravoBio, China, presented on the topic of Novel Vaccines for Emerging Diseases. BravoBio was founded in 2011 with its  headquarters in Shanghai and multiple sites in China. …

Vaccine Asia Live: Recombinant Lipoimmunogen-based therapeutic HPV Vaccine

Human Papilloma Virus(HPV) is a DNA virus that can cause skin & genital warts as well as cervical and osopharyngeal cancers. In the US, there is an increasing trend in cervical cancer in women and osopharyngeal cancer in men.  To make things worse, there are no treatments available for HPV infection. Thus, HPV vaccines have become the most common mode …

Vaccine Asia Live: Forging Strategic Partnership for R&D to Meet High Demands for Vaccines in Asia

As a unique feature of Terrapinn conferences, the roundtable discussions serve as an interactive platform for meaningful discussion. At World Vaccine Congress Asia 2014, Do Tuan Dat, President & General Director of Vabiotech, Vietnam, moderated the discussion on the topic of “Forging Strategic Partnership for R&D to Meet High Demands for Vaccines in Asia”. A consensus was reached among the …

Vaccine Asia Live: Accelerating Vaccine Development in Asia through Public-Private Partnership(PPP)

Live at World Vaccine Congress Asia 2014, the day was opened with a panel discussion on accelerating vaccine deelopment in Asia through Public-Private Partnerships(PPP). Andrew Potter, CEO of PREVENT Canada moderated the discussion with Lanling Zou of NIAID USA, Duane Gubler of SUKW-NUS Graduate Medical School Singapore  and Stephen Cook of GSK Belgium. It was a great start to a …

Presentation: Preventing zoonotic influenza Infection through continued surveillance of swine and Avian influenza virus

  At the last Influenza Summit Asia, part of World Vaccine Congress Asia 2013, Cissy B. Kartasasmita of Indonesian Influenza Foundation gave the following presentation entitled: Preventing zoonotic influenza Infection through continued surveillance of swine and Avian influenza virus. Download this presentation today! Some of the points covered during the presentation include: Influenza control and surveillance in Indonesia Avian influenza …

Download survey results now: Industry stakeholders share their views on the Asian vaccine industry

The global vaccine market is growing rapidly, having seen double-digit growth for the last 10 years. Without a doubt, Asia is now seen as a highly lucrative and important market for global vaccine manufacturers to break into. According to estimations, the vaccine market is expected to grow from $2.3 billion back in 2006 to $16.6 billion by 2016 with biggest …

Download infograph: Top 5 infectious diseases in Asia

Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi; the diseases can be spread, directly or indirectly, from one person to another. In Asia, infectious diseases account for 40% of the 14 million deaths in Southeast Asia. Some of the top infectious diseases in Asia, include diarrhoea, tuberculosis and malaria. Government, NGOs, pharmas and biotechs …